Overview
Hereditary fructose intolerance (HFI), also known as fructose-1,6-bisphosphate aldolase B deficiency or aldolase B deficiency, is a rare inherited metabolic disorder caused by a deficiency of the enzyme aldolase B (fructose-1,6-bisphosphate aldolase) in the liver, kidneys, and small intestine. This enzyme is essential for the metabolism of fructose. When individuals with HFI ingest fructose, sucrose (table sugar), or sorbitol, the accumulation of fructose-1-phosphate in these organs leads to toxic effects including severe hypoglycemia, nausea, vomiting, abdominal pain, and bloating. The disease is caused by pathogenic variants in the ALDOB gene located on chromosome 9q31.1. Symptoms typically first appear in infancy when fructose-containing foods (such as fruits, juices, or sweetened formulas) are introduced into the diet. Acute episodes following fructose ingestion can cause sweating, trembling, confusion, and lethargy due to profound hypoglycemia. Chronic or repeated exposure to fructose can lead to progressive liver damage (hepatomegaly, jaundice, cirrhosis), renal tubular dysfunction (proximal renal tubular acidosis), failure to thrive, and potentially life-threatening liver and kidney failure. Coagulopathy and lactic acidosis may also occur during acute episodes. The cornerstone of treatment is strict lifelong dietary avoidance of fructose, sucrose, and sorbitol. When the diagnosis is made early and the diet is adhered to rigorously, individuals with HFI can lead normal, healthy lives with an excellent prognosis. Many affected individuals develop a natural aversion to sweet foods. Diagnosis is confirmed through molecular genetic testing of the ALDOB gene or, less commonly, by enzymatic assay of liver biopsy tissue. Intravenous glucose administration is the emergency treatment for acute hypoglycemic episodes. Patients should also be cautious about medications and intravenous solutions that may contain fructose, sucrose, or sorbitol as excipients.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Hereditary fructose intolerance.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hereditary fructose intolerance at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hereditary fructose intolerance.
Community
No community posts yet. Be the first to share your experience with Hereditary fructose intolerance.
Start the conversation →Latest news about Hereditary fructose intolerance
No recent news articles for Hereditary fructose intolerance.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hereditary fructose intolerance
What is Hereditary fructose intolerance?
Hereditary fructose intolerance (HFI), also known as fructose-1,6-bisphosphate aldolase B deficiency or aldolase B deficiency, is a rare inherited metabolic disorder caused by a deficiency of the enzyme aldolase B (fructose-1,6-bisphosphate aldolase) in the liver, kidneys, and small intestine. This enzyme is essential for the metabolism of fructose. When individuals with HFI ingest fructose, sucrose (table sugar), or sorbitol, the accumulation of fructose-1-phosphate in these organs leads to toxic effects including severe hypoglycemia, nausea, vomiting, abdominal pain, and bloating. The diseas
How is Hereditary fructose intolerance inherited?
Hereditary fructose intolerance follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hereditary fructose intolerance typically begin?
Typical onset of Hereditary fructose intolerance is infantile. Age of onset can vary across affected individuals.
Which specialists treat Hereditary fructose intolerance?
8 specialists and care centers treating Hereditary fructose intolerance are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.